Literature DB >> 14689038

Autoantibody production in chronic idiopathic urticaria is not associated with Helicobacter pylori infection.

A M Atta1, M Z A Rodrigues, C P Sousa, M Medeiros Júnior, M L B Sousa-Atta.   

Abstract

Chronic idiopathic urticaria (CIU) is a dermatological syndrome, characterized by raised erythematous skin lesions, that affects 20% of the general population and has been associated with autoimmunity. However, some reports have also suggested a close relationship between CIU and Helicobacter pylori infection, which is endemic in developing countries and associated with chronic gastritis, peptic ulcer disease, and gastric carcinoma. In the present study, we investigated the occurrence of autoantibodies in sera from 23 CIU subjects infected with H. pylori and from 23 CIU subjects without this infection. The presence of anti-thyroid antibodies was determined by indirect hemagglutination assay and the presence of autoantibodies to IgE and C1INH was determined by ELISA. Antibodies to thyroid antigens were detected at low titers from 100 to 400 in three of 23 (13%) CIU-infected subjects and in four of 23 (17%) CIU-noninfected subjects. The titers of anti-IgE autoantibodies were similar in these CIU groups, presenting absorbances of 1.16 +/- 0.09 and 1.07 +/- 0.16, respectively, while a titer of 1.14 +/- 0.15 was detected in the healthy control group. The concentration of anti-C1INH autoantibodies was the same in the CIU-infected and -noninfected subjects (7.28 +/- 1.31 and 7.91 +/- 2.45 ng/ml, respectively), and was 7.20 +/- 2.25 ng/ml in the healthy control group. However, the serum levels of complexed anti-C1INH antibodies were increased in CIU-infected subjects compared to CIU-noninfected subjects and healthy controls with an absorbance of 1.51 +/- 0.21 vs 1.36 +/- 0.16 and 1.26 +/- 0.23, respectively (P<0.05), indicating an impaired clearance of immune complexes in CIU-infected patients. In conclusion, no correlation was observed between H. pylori infection and autoantibody production in CIU patients consistent with reports of clinical studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14689038     DOI: 10.1590/s0100-879x2004000100002

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  7 in total

Review 1.  Chronic idiopathic urticaria and Graves' disease.

Authors:  R M Ruggeri; S Imbesi; S Saitta; A Campennì; S Cannavò; F Trimarchi; S Gangemi
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

Review 2.  Immunoglobulin E-Mediated Autoimmunity.

Authors:  Marcus Maurer; Sabine Altrichter; Oliver Schmetzer; Jörg Scheffel; Martin K Church; Martin Metz
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

3.  Anti-TPO IgE Autoantibody in Chronic Urticaria: Is It Clinically Relevant?

Authors:  Bastsetseg Ulambayar; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2019-01       Impact factor: 5.764

4.  Graves' Disease Presenting as Urticaria.

Authors:  Mohammed A Al Rushud; Mohammed Gaffar Mohammed; Abdulrahman Murshid; Saud Almuammar; Abdullah M AlHossan
Journal:  Cureus       Date:  2020-12-17

5.  Role of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: A Propensity Score Matching Analysis.

Authors:  Yan Guo; Hua-Ming Li; Wei-Qin Zhu; Zhen Li
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-02-05

6.  Chronic urticaria associated with lung adenocarcinoma - a paraneoplastic manifestation: A case report and literature review.

Authors:  Luisa Fernanda Jiménez; Evis Adriana Castellón; Juan David Marenco; José Maria Mejía; Camilo Andrés Rojas; Franklin Torres Jiménez; Linda Coronell; Estefanie Osorio-Llanes; Evelyn Mendoza-Torres
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

7.  Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria.

Authors:  Takahiro Endo; Shota Toyoshima; Koremasa Hayama; Maho Tagui; Yusuke Niwa; Mana Ito; Tadashi Terui; Yoshimichi Okayama
Journal:  Asia Pac Allergy       Date:  2020-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.